1. Home
  2. STRA vs GLUE Comparison

STRA vs GLUE Comparison

Compare STRA & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STRA

Strategic Education Inc.

HOLD

Current Price

$75.33

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Monte Rosa Therapeutics Inc.

GLUE

Monte Rosa Therapeutics Inc.

HOLD

Current Price

$18.31

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRA
GLUE
Founded
2017
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
STRA
GLUE
Price
$75.33
$18.31
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$87.00
$32.00
AVG Volume (30 Days)
203.1K
904.2K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
3.04%
N/A
EPS Growth
15.85
N/A
EPS
1.48
N/A
Revenue
$997,137,000.00
$123,672,000.00
Revenue This Year
$4.71
N/A
Revenue Next Year
$4.67
$2.45
P/E Ratio
$50.49
$72.42
Revenue Growth
57.23
63.54
52 Week Low
$69.70
$4.12
52 Week High
$88.50
$25.77

Technical Indicators

Market Signals
Indicator
STRA
GLUE
Relative Strength Index (RSI) 39.73 51.65
Support Level $75.10 $17.07
Resistance Level $83.97 $18.66
Average True Range (ATR) 2.20 1.20
MACD -0.54 0.10
Stochastic Oscillator 23.42 58.67

Price Performance

Historical Comparison
STRA
GLUE

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).

Share on Social Networks: